These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 17222546

  • 1. Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy.
    Chun FK, Briganti A, Jeldres C, Gallina A, Erbersdobler A, Schlomm T, Walz J, Eichelberg C, Salomon G, Haese A, Currlin E, Ahyai SA, Bénard F, Huland H, Graefen M, Karakiewicz PI.
    Eur J Cancer; 2007 Feb; 43(3):536-43. PubMed ID: 17222546
    [Abstract] [Full Text] [Related]

  • 2. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer.
    Nelson BA, Shappell SB, Chang SS, Wells N, Farnham SB, Smith JA, Cookson MS.
    BJU Int; 2006 Jun; 97(6):1169-72. PubMed ID: 16686706
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of a positive surgical margin in pathologically organ-confined prostate cancer.
    Ahyai SA, Zacharias M, Isbarn H, Steuber T, Eichelberg C, Köllermann J, Fisch M, Karakiewicz PI, Huland H, Graefen M, Chun FK.
    BJU Int; 2010 Aug; 106(4):478-83. PubMed ID: 20128781
    [Abstract] [Full Text] [Related]

  • 4. Percentage of high-grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason score.
    Hansen J, Bianchi M, Sun M, Rink M, Castiglione F, Abdollah F, Steuber T, Ahyai SA, Steurer S, Göbel C, Freschi M, Montorsi F, Shariat SF, Fisch M, Graefen M, Karakiewicz PI, Briganti A, Chun FK.
    BJU Int; 2014 Mar; 113(3):399-407. PubMed ID: 24053339
    [Abstract] [Full Text] [Related]

  • 5. Visual estimation of tumour extent is not an independent predictor of prostate specific antigen recurrence.
    Jones TD, Koch MO, Lin H, Cheng L.
    BJU Int; 2005 Dec; 96(9):1253-7. PubMed ID: 16287440
    [Abstract] [Full Text] [Related]

  • 6. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U, Scattoni V, Freschi M, Briganti A, Salonia A, Gallina A, Colombo R, Karakiewicz PI, Rigatti P, Montorsi F.
    Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
    [Abstract] [Full Text] [Related]

  • 7. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
    May M, Knoll N, Siegsmund M, Fahlenkamp D, Vogler H, Hoschke B, Gralla O.
    J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
    [Abstract] [Full Text] [Related]

  • 8. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression?
    Pfitzenmaier J, Pahernik S, Tremmel T, Haferkamp A, Buse S, Hohenfellner M.
    BJU Int; 2008 Nov; 102(10):1413-8. PubMed ID: 18537951
    [Abstract] [Full Text] [Related]

  • 9. Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
    Briganti A, Chun FK, Hutterer GC, Gallina A, Shariat SF, Salonia A, Scattoni V, Valiquette L, Montorsi F, Rigatti P, Graefen M, Huland H, Karakiewicz PI.
    Eur Urol; 2007 Sep; 52(3):733-43. PubMed ID: 17350750
    [Abstract] [Full Text] [Related]

  • 10. Tumor volume does not predict for biochemical recurrence after radical prostatectomy in patients with surgical Gleason score 6 or less prostate cancer.
    Merrill MM, Lane BR, Reuther AM, Zhou M, Magi-Galluzzi C, Klein EA.
    Urology; 2007 Aug; 70(2):294-8. PubMed ID: 17826492
    [Abstract] [Full Text] [Related]

  • 11. The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens.
    Marks RA, Koch MO, Lopez-Beltran A, Montironi R, Juliar BE, Cheng L.
    Hum Pathol; 2007 Aug; 38(8):1207-11. PubMed ID: 17490720
    [Abstract] [Full Text] [Related]

  • 12. Impact of patient age on biochemical recurrence rates following radical prostatectomy.
    Magheli A, Rais-Bahrami S, Humphreys EB, Peck HJ, Trock BJ, Gonzalgo ML.
    J Urol; 2007 Nov; 178(5):1933-7; discussion 1937-8. PubMed ID: 17868723
    [Abstract] [Full Text] [Related]

  • 13. Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stage.
    Budäus L, Isbarn H, Eichelberg C, Lughezzani G, Sun M, Perrotte P, Chun FK, Salomon G, Steuber T, Köllermann J, Sauter G, Ahyai SA, Zacharias M, Fisch M, Schlomm T, Haese A, Heinzer H, Huland H, Montorsi F, Graefen M, Karakiewicz PI.
    J Urol; 2010 Oct; 184(4):1341-6. PubMed ID: 20723925
    [Abstract] [Full Text] [Related]

  • 14. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.
    Magheli A, Rais-Bahrami S, Carter HB, Peck HJ, Epstein JI, Gonzalgo ML.
    J Urol; 2007 Oct; 178(4 Pt 1):1277-80; discussion 1280-1. PubMed ID: 17698121
    [Abstract] [Full Text] [Related]

  • 15. Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
    Walz J, Chun FK, Klein EA, Reuther A, Graefen M, Huland H, Karakiewicz PI.
    Eur Urol; 2009 Feb; 55(2):412-19. PubMed ID: 19027223
    [Abstract] [Full Text] [Related]

  • 16. Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy.
    Suekane S, Noguchi M, Nakashima O, Yamada S, Kojiro M, Matsuoka K.
    Int J Urol; 2007 Aug; 14(8):713-8. PubMed ID: 17681061
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
    Smith JA, Chan RC, Chang SS, Herrell SD, Clark PE, Baumgartner R, Cookson MS.
    J Urol; 2007 Dec; 178(6):2385-9; discussion 2389-90. PubMed ID: 17936849
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of surgical margin status for biochemical recurrence following radical prostatectomy.
    Hashimoto K, Masumori N, Takei F, Fukuta F, Takahashi A, Itoh N, Hasegawa T, Tsukamoto T.
    Jpn J Clin Oncol; 2008 Jan; 38(1):31-5. PubMed ID: 18203710
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
    Boorjian SA, Thompson RH, Siddiqui S, Bagniewski S, Bergstralh EJ, Karnes RJ, Frank I, Blute ML.
    J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
    [Abstract] [Full Text] [Related]

  • 20. The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system.
    van Oort IM, Witjes JA, Kok DE, Kiemeney LA, Hulsbergen-Van De Kaa CA.
    BJU Int; 2008 Aug; 102(4):438-41. PubMed ID: 18336608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.